111 related articles for article (PubMed ID: 312171)
1. Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.
Kateley JR; Bazzell SJ
Clin Exp Immunol; 1979 Feb; 35(2):218-26. PubMed ID: 312171
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal study of immunological parameters in multiple sclerosis: cell-mediated immunity and complement profiles.
Mar P; Gradl T; Dörner C; Contag I
Clin Exp Immunol; 1979 Jun; 36(3):442-8. PubMed ID: 487645
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of formation of active T-rosette forming cells in multiple sclerosis patients].
Matveeva TV; D'iakonova IN; Shaĭdullina FS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):21-5. PubMed ID: 6972132
[TBL] [Abstract][Full Text] [Related]
4. Dual response of lymphocytes from multiple sclerosis patients to myelin basic protein.
Wicher V; Olszewski W; Milgrom F
Clin Exp Immunol; 1979 Jul; 37(1):114-9. PubMed ID: 90569
[TBL] [Abstract][Full Text] [Related]
5. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
[TBL] [Abstract][Full Text] [Related]
6. [Experience in using T-activin in multiple sclerosis patients].
Gusev EI; Arion VIa; Aristova RA; Ivanokov AN; Tunkel' OI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):168-74. PubMed ID: 6608843
[TBL] [Abstract][Full Text] [Related]
7. Defective mitogenic responses in myasthenia gravis and multiple sclerosis.
Dropcho EJ; Richman DP; Antel JP; Arnason BG
Ann Neurol; 1982 May; 11(5):456-62. PubMed ID: 6980619
[TBL] [Abstract][Full Text] [Related]
8. [Functional properties of T-lymphocytes in patients with multiple sclerosis].
Zleleznova TA; Ierusalimskiĭ AP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):19-23. PubMed ID: 2529722
[TBL] [Abstract][Full Text] [Related]
9. [Thymus-dependent and thymus-independent blood lymphocytes in multiple sclerosis].
Khondkarian OA; Gannushkina IV; Zavalishin IA; Zhirnova IG; Nevskaia OM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):32-6. PubMed ID: 6602442
[TBL] [Abstract][Full Text] [Related]
10. Identification of three FcR-positive T cell subsets (T gamma, T mu and T gamma mu) in the cerebrospinal fluid of multiple sclerosis patients.
Merrill JE; Biberfeld G; Landin S; Sidén A; Norrby E
Clin Exp Immunol; 1980 Nov; 42(2):345-54. PubMed ID: 6970641
[TBL] [Abstract][Full Text] [Related]
11. [Thymus-dependent lymphocytes in multiple sclerosis and amyotrophic lateral sclerosis].
Loseva TM; Khondkarian OA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):182-7. PubMed ID: 305707
[TBL] [Abstract][Full Text] [Related]
12. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
13. Direct leukocyte migration inhibition by myelin basic protein in exacerbations of multiple sclerosis.
Sheremata W; Triller H; Cosgrove JB; Eylar EH
Can Med Assoc J; 1977 May; 116(9):985-8. PubMed ID: 870161
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-induced plasma cell differentiation in patients with multiple sclerosis.
Levitt D; Griffin NB; Egan ML
J Immunol; 1980 May; 124(5):2117-21. PubMed ID: 6965966
[TBL] [Abstract][Full Text] [Related]
15. [Status of local and general immunity in patients with multiple sclerosis].
Totolian NA; Skoromets AA; Barbas IM; Smirnov AIu
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):20-2. PubMed ID: 1647617
[TBL] [Abstract][Full Text] [Related]
16. Abnormal regulation of in vitro IgG production in multiple sclerosis.
Kelly RE; Ellison GW; Myers LW; Goymerac V; Larrick SB; Kelley CC
Ann Neurol; 1981 Mar; 9(3):267-72. PubMed ID: 6452852
[TBL] [Abstract][Full Text] [Related]
17. T lymphocyte redistribution between peripheral blood and cerebrospinal fluid in active multiple sclerosis.
Biglino A; Baggio GF; Gioannini P
Boll Ist Sieroter Milan; 1984 May; 63(2):150-3. PubMed ID: 6235822
[TBL] [Abstract][Full Text] [Related]
18. [Lymphocyte subpopulations in multiple sclerosis (MS). A contribution].
Nuccetelli F; Assetta M; Tartaro A; Di Muzio A; Nanni Costa E; Anichini M; Gambi D
Minerva Med; 1989 Mar; 80(3):189-93. PubMed ID: 2654756
[TBL] [Abstract][Full Text] [Related]
19. PHA skin test-correlation with migration inhibition but not with peripheral blood lymphocytes (PBL) subpopulations. With 1 figure.
Szczylik C; Wiktor-Jedrzejczak W
Allerg Immunol (Leipz); 1981; 27(3):162-7. PubMed ID: 6214937
[TBL] [Abstract][Full Text] [Related]
20. [Use of a thymus polypeptide preparation to diagnose and correct immune deficiency states in multiple sclerosis].
Golovkin VI; Ankhimova ES; Morozov VG; Khavinson VG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):179-82. PubMed ID: 6201026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
